MOMS Project Panel Overview

Size: px
Start display at page:

Download "MOMS Project Panel Overview"

Transcription

1 MOMS Project Panel Overview Rick Massatti, PhD, Ohio Department of Mental Health and Addiction Services Jennifer Bailit, MD, MetroHealth Medical Center Mike Marcotte, MD, Tri-Health Mona Prasad, DO,MPH, -OSU-MCH Through collaborative use of improvement science methods, reduce preterm births & improve perinatal and preterm newborn outcomes in Ohio as quickly as possible.

2 MOMS Project

3 Maternal Opiate Medical Supports In August 2013, the Kasich Administration announced plans to address the epidemic of NAS Maternal Opiate Medical Supports (MOMS) project is a two-year quality improvement initiative that seeks to: Improve maternal and fetal outcome Improve family stability Reduce costs of Neonatal Abstinence Syndrome (NAS)

4 Project Partners State Sponsors Office of Health Transformation Department of Mental Health and Addiction Services Department of Medicaid Pilot Sites CompDrug First Step Home Health Recovery Services MetroHealth Medical Center Clinical Advisory Panel Project Management and Data Infrastructure Ohio Colleges of Medicine Government Resource Center Quality Improvement Vendor Health Services Advisory Group

5 Project Details $4.2 million program over two years Goal was to support interventions and prenatal treatments that improve outcomes for 300 women and babies Funded clinical (e.g., MAT) and non-clinical services (e.g., housing vouchers, transportation, brief babysitting)

6

7 Neonatal Abstinence Syndrome in Ohio Rick Massatti, PhD

8 Methods Ohio Hospital Association Statewide clinical and financial database Data submitted by 219 hospitals and 13 health systems. Approximately 99 percent of healthcare systems submit data A few caveats... Aggregate data used Analyses limited to resident Ohioans

9 Neonatal Abstinence Syndrome (NAS) Hospitalizations for NAS Cases were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9 CM) code (drug withdrawal syndrome in a newborn). Records for infants (age < 1) were pulled if they had applicable ICD-9 CM codes anywhere in discharge fields related to the primary diagnosis or any of the 18 secondary diagnosis fields. The ICD-9 CM code does not distinguish between NAS caused by drugs ingested by the mother versus NAS caused by drugs legitimately given by delivering physicians. The diagnosis of NAS does not include a diagnosis of Fetal Alcohol Spectrum Disorder (ICD-9 CM ).

10 Mother s Drug Abuse at Child s Birth Over 28,800 women were diagnosed with a variety of drug abuse and dependence conditions at their time of delivery between 2004 and The number of delivering women with an abuse or dependence diagnosis increased from 1,554 in 2004 to 4,349 in 2014 (179.9%). Annual diagnosis rates for delivering mothers tripled from 103 per 10,000 live births in 2004 to 310 per 10,000 live births in 2014.

11 Drug Diagnoses at Child s Birth 3,000 2,500 Number of Diagnoses 2,000 1,500 1,000 Marijuana Opiate Cocaine Other* Year A woman could have multiple diagnoses * Other may refer to drugs like hallucinogens and amphetamines Source: Ohio Hospital Association

12 NAS in Ohio Increased opiate use led to the increased prevalence of NAS In 2014, there were 1,875 NAS inpatient admissions according to the Ohio Hospital Association.

13 NAS Statewide Rate per 10k Rate per 10, Year Source: Ohio Hospital Association

14 Rate Comparison per 10k NAS Rate MOMS Rate Source: Ohio Hospital Association

15 NAS Cost As NAS cases became more prevalent, inflationadjusted total inpatient costs associated with NAS increased. From $6.5 million in 2004 to $105.2 million in 2014

16 NAS Length of Stay (LOS) Average LOS (days) Year Source: Ohio Hospital Association NAS Infants All Infants

17 Health Outcomes NAS Infants Year Feeding difficulties Low birth weight Respiratory symptoms Seizure & Convulsion All Ohio Infants Year Feeding difficulties Low birth weight Respiratory symptoms Seizure & Convulsion An infant could have multiple diagnoses Source: Ohio Hospital Association

18 Health Outcomes NAS Infants Year Feeding difficulties 20.80% 20.60% 23.00% 20.70% 22.00% 20.71% 18.51% 16.55% 15.29% 16.73% Low birth weight 32.00% 28.80% 32.30% 25.60% 29.10% 32.04% 26.85% 26.19% 25.48% 25.31% Respiratory symptoms 36.80% 37.70% 40.30% 35.50% 36.20% 30.31% 29.80% 23.25% 24.76% 22.79% Seizure & Convulsion 3.00% 3.10% 2.70% 2.30% 2.60% 1.83% 1.13% 1.40% 0.90% 1.39% All Ohio Infants Year Feeding difficulties 3.10% 3.30% 3.40% 3.60% 3.70% 4.10% 4.31% 4.44% 4.85% 4.79% Low birth weight 11.10% 11.30% 11.70% 11.50% 11.60% 12.10% 11.90% 12.30% 12.39% 12.74% Respiratory symptoms 10.00% 10.00% 9.90% 9.80% 9.80% 10.10% 9.85% 9.88% 9.81% 10.02% Seizure & Convulsion 0.30% 0.30% 0.30% 0.20% 0.20% 0.20% 0.22% 0.22% 0.22% 0.19% An infant could have multiple diagnoses Source: Ohio Hospital Association

19 19

20 20

21 21

22 22

23 23

24

25

26 NAS Rate by OPQC Region Based on Patient Residence Akron/Canton/Youngstown (Northeastern) Toledo (Northwestern) Cincinnati (Western) Dayton (Southwestern) Cleveland (North Central) Appalachia (Southeastern) Columbus (Central) Source: Ohio Hospital Association

27 Raw Numbers by OPQC Region Akron/Canton/ Youngstown (Northeastern) Cleveland (North Central) Toledo (Northwestern) Appalachia (Southeastern) Cincinnati (Western) Columbus (Central) Dayton (Southwestern) Source: Ohio Hospital Association

28 Contact Information Rick Massatti, PhD, MSW, MPH, LSW Ohio Dept. of Mental Health & Addiction Services 30 East Broad Street, 36 th Floor Columbus, Ohio Phone (614)

29 Mother and Child Dependency Program MetroHealth Medical System Hospital based program Care coordination and social work Pediatrics (neonatal and community based) MAT provided by community, not at MetroHealth ~180 women in a year o 56% have Hepatitis C o 41.4% had previous children in DCFS custody o 33.8% were victims of assault o 12% admitted to prostitution o 90% have used heroin o 61% starting with Rx opioids o 27% are positive for opiates at delivery

30 Cincinnati MOMS Project Maternal Addiction Program Behavioral Health Therapy Inpatient/ Residential Care Intensive Outpatient Therapy Wrap Around Services HOPE Prenatal Care/ Case Management Inpatient MAT induction Referral to community MAT and addiction treatment Enhanced Prenatal Care Delivery Enhanced Postpartum Care Medication Assisted Treatment Medication Assisted Treatment Outpatient Buprenorphine Therapy Addiction Medicine

31 MOMS Franklin County Partners MRC Clinic

32 Questions for the Panelists

The Impact of Addiction on Infant Mortality

The Impact of Addiction on Infant Mortality Congressional Addiction, Treatment and Recovery Caucus and the Bipartisan Task Force to Combat the Heroin Epidemic Hosts: The Impact of Addiction on Infant Mortality Arthur R. James MD, FACOG Ohio State

More information

Ohio Perinatal Quality Collaborative

Ohio Perinatal Quality Collaborative Ohio Perinatal Quality Collaborative Neonatal Abstinence Syndrome Project Presented by Michele Walsh MD Neonatal Lead Physician December 2017 Disclosure I have no financial or other conflicts of interest.

More information

Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health

Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health Columbus, Ohio Assignment Description The rapid advance of the opiate crisis has had far

More information

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home

More information

Opioid use in pregnancy and Neonatal Abstinence Syndrome

Opioid use in pregnancy and Neonatal Abstinence Syndrome Opioid use in pregnancy and Neonatal Abstinence Syndrome Morissa Ladinsky, MD Assoc. Professor of Pediatrics Division of General Pediatrics and Adolescent Medicine UAB Objectives 1. Understand the magnitude,

More information

Mental and Behavioral Health

Mental and Behavioral Health Mental and Behavioral Health Mental Health Poor mental health is a major source of distress, disability, and social burden. In any given year, as many as one in five adults in the United States have a

More information

Smoke Free Families Informational Webinar August 23, 2018

Smoke Free Families Informational Webinar August 23, 2018 The Ohio Perinatal Quality Collaborative Mission: Through collaborative use of improvement science methods, to reduce preterm births & improve perinatal and preterm newborn outcomes in Ohio as quickly

More information

Neonatal Abstinence Syndrome (NAS)

Neonatal Abstinence Syndrome (NAS) Neonatal Abstinence Syndrome (NAS) Jodi Jackson, MD Neonatologist Children's Mercy Hospital Associate Professor of Pediatrics University of Missouri-Kansas City School of Medicine Medical director NICU

More information

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016 Care of the Neonate with Prenatal Opioid Exposure Heather Pratt Chavez, MD Ann Winegardner, MD Objectives Review the latest population data on neonates with prenatal opioid exposure Describe the acute

More information

Opioid Abuse Treatment in Pregnancy

Opioid Abuse Treatment in Pregnancy University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2015 Opioid Abuse Treatment in Pregnancy Catherine A. Suppan Follow this and additional works

More information

Emerging Populations: Challenges for the Early Childhood System. Presented by Maureen Greer

Emerging Populations: Challenges for the Early Childhood System. Presented by Maureen Greer Emerging Populations: Challenges for the Early Childhood System Presented by Maureen Greer Early Intervention/Early Childhood Special Interest Group (EIEC SIG) Webinar Series September 26, 2017 Presenter

More information

EI Leadership April 24, 2018

EI Leadership April 24, 2018 Early Childhood Community Partnerships to Support Families Struggling with SUD EI Leadership April 24, 2018 Setting the Stage The issue of young children impacted by substance use disorders in families

More information

Welcome to the OPQC NAS November Action Period Call

Welcome to the OPQC NAS November Action Period Call Welcome to the OPQC NAS November Action Period Call Thank you for joining; our webinar will start shortly! In the mean time; please sign in the chat box the names of all webinar participants and full name

More information

Effects of Prenatal Illicit Drug. Use on Infant and Child

Effects of Prenatal Illicit Drug. Use on Infant and Child Effects of Prenatal Illicit Drug Use on Infant and Child Development Andrew Hsi, MD, MPH Larry Leeman, MD, MPH Family Medicine MCH Grand Rounds 6 July 2011 Objectives for Presentation At the end of this

More information

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome?

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome? Care of the Neonate with Prenatal Opioid Exposure Heather Pratt Chavez, MD Ann Winegardner, MD Objectives Review the latest population data on neonates with prenatal opioid exposure Describe the acute

More information

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome Opioid Use Disorder in Pregnancy Neonatal Abstinence Syndrome Opioid Use Disorder and Pregnancy Cont. 4.6 million women (or 3.8 percent) ages 18 and older misused prescription drugs in 2013. One-third

More information

Substance-Exposed Newborns

Substance-Exposed Newborns Substance-Exposed Newborns State of Oklahoma 2017 Substance-Exposed Newborns State of Oklahoma 2017 Legal Background Oklahoma statute, Title 63, 1-550.3, states, "The Department of Human Services shall

More information

Opiate Abuse and the Growing Impact on Maternal and Child Health in West Virginia. Overview

Opiate Abuse and the Growing Impact on Maternal and Child Health in West Virginia. Overview Opiate Abuse and the Growing Impact on Maternal and Child Health in West Virginia Christina, Director Office of Maternal, Child and Family Health Bureau for Public Health October 23, 2017 Overview Describe

More information

Child Welfare and MOMS: Building Partnerships to Improve Care

Child Welfare and MOMS: Building Partnerships to Improve Care Child Welfare and MOMS: Building Partnerships to Improve Care Goals Develop collaborative partnerships between MOMS pilot sites and child welfare agencies: Facilitate successful outcomes for clients Jointly

More information

Perinatal Opioid Use: Understanding and Aligning Response between Systems

Perinatal Opioid Use: Understanding and Aligning Response between Systems Perinatal Opioid Use: Understanding and Aligning Response between Systems Dorothy J. Mandell, PhD Population Health University of Texas System & University of Texas Health Science Center, Tyler The Team

More information

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Objectives Discuss the current scope of maternal substance use and abuse List examples

More information

Clinical Management of Neonatal Abstinence Syndrome. Tricia L. Romesberg, DNP, MSN, ARNP, CNNP

Clinical Management of Neonatal Abstinence Syndrome. Tricia L. Romesberg, DNP, MSN, ARNP, CNNP Clinical Management of Neonatal Abstinence Syndrome Tricia L. Romesberg, DNP, MSN, ARNP, CNNP Timeline Incidence of NAS Healthcare Cost and Utilization Project (HCUP), 1999-2013 State Inpatient Databases

More information

New Jersey Mental Health and Addiction Providers Meeting April 26, Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health

New Jersey Mental Health and Addiction Providers Meeting April 26, Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health New Jersey Mental Health and Addiction Providers Meeting April 26, 2018 Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health DOH Healthcare & Public Health Priorities Reduce disparities

More information

Methadone and Pregnancy

Methadone and Pregnancy Methadone and Pregnancy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Charissa Patricelli, MD, CCFP, ABAM Clinical Associate Professor, Dept. of Family Practice UBC American Board of Addiction Medicine

More information

Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC

Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC Emergent Issues Affecting Early Intervention/ Early Childhood Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC Conversation Points Changing Demographics Emergent Trends

More information

MATERNAL MORTALITY IN TEXAS Using Precision Public Health to Improve Maternal Outcomes

MATERNAL MORTALITY IN TEXAS Using Precision Public Health to Improve Maternal Outcomes MATERNAL MORTALITY IN TEXAS Using Precision Public Health to Improve Maternal Outcomes In an article by MacDorman et al. appearing in the 2016 September issue of Obstetrics and Gynecology, McDorman s data

More information

NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE

NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE Salma Ali MD, Debra Brendel RN, BSN, MSN and Ona Fofah MD Division of Neonatology and Newborn Medicine Department of

More information

The Opioid-Exposed Woman

The Opioid-Exposed Woman The Opioid-Exposed Woman Management Considerations for Labor and Delivery Jane Sublette, MS, RN, CNM, WHNP-BC Fairview Ridges Hospital Objectives Describe opioid-associated risks to the mother and fetus

More information

The Role of Opioid Overdoses in Confirmed Maternal Deaths,

The Role of Opioid Overdoses in Confirmed Maternal Deaths, The Role of Opioid Overdoses in Confirmed Maternal Deaths, 2012-2015 Introduction The Department of State Health Services (DSHS) conducted an analysis of maternal deaths resulting from drug overdoses from

More information

Opioids in Pregnancy. Beyond to Baby GENERAL INFO

Opioids in Pregnancy. Beyond to Baby GENERAL INFO Opioids in Pregnancy and Beyond to Baby by Marcia W. VanVleet, MD, MPH Medical Director, Newborn Service Team, Women and Infants Hospital, and Assistant Professor of Pediatrics, Brown Alpert Medical School,

More information

Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC.

Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC. Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC Key Issues Significant increase in number of pregnant women addicted to prescription

More information

Substance-Exposed Newborns

Substance-Exposed Newborns Substance-Exposed Newborns State of Oklahoma 2016 Substance-Exposed Newborns State of Oklahoma 2016 Legal Background Federal guidelines in the Child Abuse Prevention and Treatment Act (CAPTA) require states

More information

4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING

4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING Opioid Use Disorder in Pregnancy 2017 Recommendations from ACOG and The Pew Charitable Trust KATHY D. HARTKE, MD, LEGISLATIVE CO-CHAIR AND IMMEDIATE PAST CHAIR, WISCONSIN SECTION OF THE AMERICAN COLLEGE

More information

Neonatal Abstinence Syndrome: Focus on Prevention and Role of Collaboratives

Neonatal Abstinence Syndrome: Focus on Prevention and Role of Collaboratives Neonatal Abstinence Syndrome: Focus on Prevention and Role of Collaboratives Brevard County Health Department Melbourne, FL April 7, 2017 Mark L. Hudak, MD Professor and Chairman of Pediatrics University

More information

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome Neonatal Nursing Education Brief: The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome https://www.seattlechildrens.org/healthcareprofessionals/education/continuing-medical-nursing-education/neonatalnursing-education-briefs/

More information

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Beyond Birth: A Comprehensive Recovery Center serving parenting women Beyond Birth: A Comprehensive Recovery Center serving parenting women Session Objectives Highlight Plan of Safe Care Introduce the Beyond Birth Comprehensive Recovery Center Describe Levels of Care The

More information

Opioid Addiction Statistics

Opioid Addiction Statistics May 2017 Opioid Addiction Statistics Definitions Heroin Epidemic - As pill mills close, prescribing is becoming tighter, demand among younger users rise, and dealer s profits rise, addicts are turning

More information

Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy

Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy Centers for Disease Control and Prevention Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy Jenna Meyer MPH, RNC-MNN, IBCLC Public Health Advisor Therapies for Opioid Dependent

More information

Outcomes of Infants with Neonatal Abstinence Syndrome

Outcomes of Infants with Neonatal Abstinence Syndrome Outcomes of Infants with Neonatal Abstinence Syndrome Caroline O. Chua, MD, FAAP Medical Director, Division of Neonatology Director, Neonatal Follow Up Clinic Nemours Children s Hospital Orlando, Florida

More information

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians ADDRESSING THE OPIOID EPIDEMIC Joint principles of the following organizations representing front-line physicians American Academy of Family Physicians American Academy of Pediatrics American College of

More information

Presented by DCF SunCoast Region: Kyle Teague, Melissa Worthen, Christina Cuoco, Nina Romeu, Dekesha Seay

Presented by DCF SunCoast Region: Kyle Teague, Melissa Worthen, Christina Cuoco, Nina Romeu, Dekesha Seay Presented by DCF SunCoast Region: Kyle Teague, Melissa Worthen, Christina Cuoco, Nina Romeu, Dekesha Seay Overview/Learning Objectives What is Addiction Medication Assisted Treatment Discuss facts about

More information

Neonatal Narcotic Abstinence Syndrome: A National Epidemic

Neonatal Narcotic Abstinence Syndrome: A National Epidemic Neonatal Narcotic Abstinence Syndrome: A National Epidemic Moira Crowley, MD Assistant Professor, Pediatrics Neonatal Faculty, NAS Project Perinatal Quality Collaborative Ohio Childrens Hospitals Neonatal

More information

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report Report to The Vermont Legislature Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report In Accordance with Act 179 () Sec. E.306.2 (a)(2) Submitted to: Submitted

More information

Safe Babies Foster Parent Training Program

Safe Babies Foster Parent Training Program Safe Babies Foster Parent Training Program Module 1: Introduction to the Safe Babies Program 1 Begin the process of group participation Learning outcomes Understand the purpose and origins of the Safe

More information

Successful Prevention Strategies to Address the Opioid Crises

Successful Prevention Strategies to Address the Opioid Crises Successful Prevention Strategies to Address the Opioid Crises Shannon Breitzman, MSW, Principal Denver Office Lindsey Kato, MPH, CHES, Consultant Denver Office 1 LEARNING OBJECTIVES + Find out how to effectively

More information

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE

More information

... Health. Department of. Prenatal Drug Exposure and Neonatal Abstinence Syndrome in Northeast TN. Overview and Regional Snapshot

... Health. Department of. Prenatal Drug Exposure and Neonatal Abstinence Syndrome in Northeast TN. Overview and Regional Snapshot Department of... Health Prenatal Drug Exposure and Neonatal Abstinence Syndrome in Northeast TN Overview and Regional Snapshot Cynthia C. Thomas, DO, MPH, Assistant Health Officer, Northeast Regional Health

More information

OPQC Learning Session: High Risk Moms & Infants. Mary Applegate, MD, FACP, FAAP Medical Director, Ohio Department of Medicaid September 2016

OPQC Learning Session: High Risk Moms & Infants. Mary Applegate, MD, FACP, FAAP Medical Director, Ohio Department of Medicaid September 2016 OPQC Learning Session: High Risk Moms & Infants Mary Applegate, MD, FACP, FAAP Medical Director, Ohio Department of Medicaid September 2016 OLD: 9/19/2016 2 Collaboration, Cooperation & Coordination Microsystems

More information

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA THE OPIOID CRISIS DEFINING THE CRISIS KATHLEEN DUPPER, MD MEDICAL DIRECTOR, HUNTSVILLE RECOVERY 19 th Annual Perinatal Conference: The Opioid Crisis September 21, 2018 DEFINING THE CRISIS NUMBER OF OPIOID-RELATED

More information

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit

More information

Creating a Safety Net for HIV Exposed Infants in Illinois

Creating a Safety Net for HIV Exposed Infants in Illinois Creating a Safety Net for HIV Exposed Infants in Illinois Perinatal HIV Elimination Project Anne Statton BA, Laurie Ayala MPH, Yolanda Olszewski MS MPH National HIV Prevention Conference December 3, 2007

More information

Maine s Response to the Opiate Crisis. Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016

Maine s Response to the Opiate Crisis. Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016 Maine s Response to the Opiate Crisis Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016 Required Disclosure Text Font typically Times New Roman at least 20 point Try

More information

Lorain County Community Health Improvement Plan Annual report

Lorain County Community Health Improvement Plan Annual report Lorain County Community Health Improvement Plan 2017 Annual report Completed July 2, 2018 Introduction In December 2012, partner agencies used data from the 2011 Lorain County Community Health Assessment

More information

Why NAS? Proposed Program

Why NAS? Proposed Program Focus Groups Provide Insight into Neonatal Abstinence Syndrome in Eastern Kentucky By Big Sandy Neonatal Abstinence Syndrome Prevention Team as part of Appalachian Leadership Academy for Public s Health

More information

Science = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse

Science = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Science = Solutions For Substance Use Disorders and Infant Outcomes Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Science = Solutions Increased Opioid Mortality: Greater

More information

Medicaid Expansion: Its Critical Role in Ohio s Response to the Addiction Crisis

Medicaid Expansion: Its Critical Role in Ohio s Response to the Addiction Crisis Medicaid Expansion: Its Critical Role in Ohio s Response to the Addiction Crisis 1 Medicaid Expansion: Its Critical Role in Ohio s Response to the Addiction Crisis Ohio expanded Medicaid in 2014 to provide

More information

Opioid Use and Other Trends

Opioid Use and Other Trends Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current

More information

Prescription for Disaster: Impact of Drugs in our Society

Prescription for Disaster: Impact of Drugs in our Society Prescription for Disaster: Impact of Drugs in our Society What you can do about the epidemic of drug abuse in our communities 1 Florida Poison Information Center-Tampa 10/26/2012 Cynthia R. Lewis-Younger,

More information

Addressing Substance Use Among Pregnant Women and New Moms

Addressing Substance Use Among Pregnant Women and New Moms ADRIANA KOHLER AND KATE MURPHY SENIOR POLICY ASSOCIATES AKOHLER@TXCHILDREN.ORG KMUPRHY@TXCHILDREN.ORG MARCH 20, 2018 Addressing Substance Use Among Pregnant Women and New Moms Opportunities to Improve

More information

Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population

Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population Dale Robinson MD,FACOG Jennifer Gonzalez RN,BSN Surgeon General s Report 2016 Office

More information

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works From the street to the NICU Richard Christensen, PA, CAS Johann Hari Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a

More information

PERINATAL TOBACCO USE

PERINATAL TOBACCO USE PERINATAL TOBACCO USE Child Fatality Task Force Meeting December 7, 2015 Erin McClain, MA, MPH You Quit, Two Quit, UNC Center for Maternal & Infant Health Percentage Women & Tobacco Use in NC 2 50 45 40

More information

Anesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a

Anesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a Appendix 1. Literature Search Databases Years Search Terms Pubmed 01/1966 1. Analgesics, Opioid a / or Opioid-related Disorders a / PsycINFO EMBASE Cochrane 09/2016 or Heroin a / or Heroin Dependence a

More information

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health March 12, 2018 Envisioning a socially just system where all New Yorkers

More information

If so, when: Demographic Information Male Transgender Height: Weight: Massachusetts Resident? Primary Language: Are you currently homeless?

If so, when: Demographic Information Male Transgender Height: Weight: Massachusetts Resident? Primary Language: Are you currently homeless? Application Form rev. 9/09 Jeremiah's Inn P.O. Box 30035 1059 Main St., Worcester, MA 01603-0035 FAX 508.793.9568 Phone 508.755.6403 Last Name: Suffix: First Name: Middle Initial: Alias: Referral Information

More information

Medication for the Treatment of Addiction (MAT)

Medication for the Treatment of Addiction (MAT) Medication for the Treatment of Addiction (MAT) Karol Kaltenbach, PhD Emeritus Professor of Pediatrics Sidney Kimmel Medical College at Thomas Jefferson University Terminology: Words Matter Medication

More information

Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome

Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome 1 Learning Objectives Become familiar with how the opioid epidemic is impacting Texas women Become familiar with Neonatal

More information

State Options for Promoting Recovery among Pregnant and Parenting Women with Opioid or Substance Use Disorder

State Options for Promoting Recovery among Pregnant and Parenting Women with Opioid or Substance Use Disorder State Options for Promoting Recovery among Pregnant and Parenting Women with Opioid or Substance Use Disorder Wednesday, October 24, 2018 1:00-2:15pm ET Supported by the Health Resources and Services Administration

More information

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION AND PREGNANCY L y n é e B r o w n, M A, C D P & D o n n a L i v i n g s t o n, R N A D A P T E D F R O M J i m W a l s h, M D Objectives: Recognize common fears and myths associated with substance

More information

2/24/2014. Bridging the Gap Between Behavioral Health and Pregnancy. My Background and Interest in the Topic... Plan for Today

2/24/2014. Bridging the Gap Between Behavioral Health and Pregnancy. My Background and Interest in the Topic... Plan for Today Bridging the Gap Between Behavioral Health and Pregnancy Amelia Mahan MSW, LCSW Behavioral Health Program Manager amahan@n3cn.org; (919) 926-3918 My Background and Interest in the Topic... Stumbled into

More information

TITLE V MATERNAL & CHILD HEALTH 5-YEAR STATE ACTION PLAN

TITLE V MATERNAL & CHILD HEALTH 5-YEAR STATE ACTION PLAN PRIORITY 1 Women have access to and receive coordinated, comprehensive services before, during and after pregnancy PRIORITY 2 Developmentally appropriate care and services are provided across the lifespan

More information

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome Meghan Howell, MD FAAP Assistant Professor of Pediatrics Clinical Director, Tulane NICU Graduate Clinic Tulane University School

More information

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD 1 The National Academies of Sciences, Engineering and Medicine Regulatory Strategies of address prescription opioidrelated harms 4 th of November, 2016 Washington DC Product Labeling to Communicate Benefits

More information

Neonatal Abstinence: The epidemic Its Impact on All of Us

Neonatal Abstinence: The epidemic Its Impact on All of Us Neonatal Abstinence: The epidemic Its Impact on All of Us Michelle Bode MD, MPH Neonatologist Crouse Hospital Assistant Professor Pediatrics SUNY Upstate Objectives & Disclosure Statement 1) The participant

More information

Indiana CTSI Retreat 2018

Indiana CTSI Retreat 2018 Indiana(University(Bloomington Indiana CTSI Retreat 2018 Medical(Science(Solutions(to(Indiana s(opioid(crisis Wednesday,(April(25,(2018 Keynote(Lecture(1( Where( Indiana(Stands:(NAS(and(the( Opioid(Epidemic

More information

2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem

2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem Substance Use Disorders Pregnancy Laura Lander, MSW, LICSW, Assistant Professor Department of Behavioral Medicine and Psychiatry, WVU Celebrating Connections Conference - April 2017 Substance Use Disorders

More information

Combating the Opiate Crisis in Ohio

Combating the Opiate Crisis in Ohio Combating the Opiate Crisis in Ohio In 2011, Gov. John R. Kasich announced the establishment of the Governor s Cabinet Opiate Action Team to fight opiate abuse in Ohio. Ohio is combating drug abuse through

More information

in Illinois Illinois Department of Public Health Perinatal Rapid Testing Initiative for Illinois (PRTII2)

in Illinois Illinois Department of Public Health Perinatal Rapid Testing Initiative for Illinois (PRTII2) Perinatal HIV Prevention in Illinois Illinois Department of Public Health Mildred Williamson, PhD, MSW, HIV/AIDS Section, IDPH Pediatric AIDS Chicago Prevention Initiative (PACPI) Perinatal Rapid Testing

More information

HELPING OUR MOST VULNERABLE POPULATIONS IMPACTED BY THE OPIOID CRISIS: PREGNANT WOMEN, THEIR INFANTS, AND THOSE RECEIVING CHILD WELFARE SERVICES

HELPING OUR MOST VULNERABLE POPULATIONS IMPACTED BY THE OPIOID CRISIS: PREGNANT WOMEN, THEIR INFANTS, AND THOSE RECEIVING CHILD WELFARE SERVICES HELPING OUR MOST VULNERABLE POPULATIONS IMPACTED BY THE OPIOID CRISIS: PREGNANT WOMEN, THEIR INFANTS, AND THOSE RECEIVING CHILD WELFARE SERVICES Learning Objectives Identify approaches for transforming

More information

Stark County Opiate Task Force

Stark County Opiate Task Force Stark County Opiate Task Force Allison Esber, MSSA, LSW, OCPSA Systems Initiative Manager April 10, 2017 Partner Solutions Informatics Forum for Next Gen Users in Behavioral Health What does StarkMHAR

More information

Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections. Framework and Response Models

Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections. Framework and Response Models Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections Framework and Response Models Oregon HIV, Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study

More information

Opioid Use Disorder- Pregnancy Principles and Myths. Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center

Opioid Use Disorder- Pregnancy Principles and Myths. Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center Opioid Use Disorder- Pregnancy Principles and Myths Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center History of NAS/NOWS Prior to 1875 infants not thought to be affected Congenital Morphinism

More information

Washington State s Overdose Epidemic

Washington State s Overdose Epidemic Caleb Banta-Green PhD MPH MSW Senior Research Scientist- Alcohol and Drug Abuse Institute Affiliate Associate Professor- School of Public Health Affiliate Faculty- Harborview Injury Prevention & Research

More information

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin

More information

Tobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH

Tobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH Tobacco Cessation for Women of Reproductive Age Erin McClain, MA, MPH Tobacco Use During Pregnancy in NC 2 1 in 10 babies in NC are born to women reporting tobacco use during pregnancy In some counties

More information

Kentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18

Kentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18 Kentucky s Plan to Address the Opioid Crisis Dr. Katherine Marks Critical Access Hospital Substance Abuse Summit March 8, 2018 2016 National Statistics Deaths per 100,000 population 25 20 15 10 5 Scope

More information

State Opioid Response (SOR) Grant

State Opioid Response (SOR) Grant State Opioid Response (SOR) Grant Adam Bucon, LSW DMHAS Provider Meeting September 20, 2018 Philip D. Murphy Governor Shereef M. Elnahal Commissioner Sheila Y. Oliver Lt. Governor NJ Opioid Statistics

More information

Prenatal Substance Abuse: Improving Outcomes

Prenatal Substance Abuse: Improving Outcomes Prenatal Substance Abuse: Improving Outcomes Jennifer Yates, MSN Family Nurse Practitioner Children s Hospital of Wisconsin Child Advocacy and Protection Services Overview Discuss the Problems Health,

More information

Wang Linhong, Deputy Director, Professor National Center for Women and Children s Health, China CDC

Wang Linhong, Deputy Director, Professor National Center for Women and Children s Health, China CDC Maternal and Child Health in China Wang Linhong, Deputy Director, Professor National Center for Women and Children s Health, China CDC Table of Contents 1 MCH Development and Situation in China 2 MCH Resources

More information

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018 Kentucky s Strategic Action Plan Katherine Marks, Ph.D. August 16, 2018 OUTLINE The state & the need The organization of a response The action plan THE STATE AND THE NEED KENTUCKY 4.4 million people 35

More information

David S. McKenna, M.D. Dayton/Montgomery County Infant Mortality Coalition Maternal-Fetal Medicine Miami Valley Hospital, Dayton OH

David S. McKenna, M.D. Dayton/Montgomery County Infant Mortality Coalition Maternal-Fetal Medicine Miami Valley Hospital, Dayton OH David S. McKenna, M.D. Dayton/Montgomery County Infant Mortality Coalition Maternal-Fetal Medicine Miami Valley Hospital, Dayton OH Describe local and state-wide efforts to improve overall birth outcomes

More information

Brief History of Methadone Maintenance Treatment

Brief History of Methadone Maintenance Treatment METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what

More information

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment DEPARTMENT OF HUMAN SERVICES (DHS) DIVISION OF MENTAL HEALTH & ADDICTION SERVICES (DMHAS) STORI INFORMATIONAL WEBINAR

More information

NEONATAL ABSTINENCE SYNDROME. NAS Kickoff 11/8/18

NEONATAL ABSTINENCE SYNDROME. NAS Kickoff 11/8/18 NEONATAL ABSTINENCE SYNDROME NAS Kickoff 11/8/18 OPIOID EPIDEMIC STATISTICS USA is 4.6% of the world s population 78 Americans die every day from opioid overdoses 66% of all illegal drug use 80% of global

More information

PERINATAL HEPATITIS B

PERINATAL HEPATITIS B PERINATAL HEPATITIS B A Prevention Strategy Douglas County Health Department, Omaha, NE Why Prevention is Important About 1.25 million people in the U.S. have chronic hepatitis B infection Hepatitis B

More information

Managing drug misuse in pregnancy and beyond

Managing drug misuse in pregnancy and beyond Managing drug misuse in pregnancy and beyond Dr Emily Finch Clinical Director Addictions CAG, South London and Maudsley Foundation NHS Trust Rachel Evans, Adfam 1 / Aims of the session Update on management

More information

Opiate Use in Reproductive Age Females

Opiate Use in Reproductive Age Females Opiate Use in Reproductive Age Females February 15, 2017 2:00 pm-3:00 pm ET In order to hear the presentation please call +1 (562) 247-8422, access code 579-542-512 All Participant Phone Lines are Muted

More information

Hospital Discharge Data

Hospital Discharge Data Hospital Discharge Data West Virginia Health Care Authority Hospitalization data were obtained from the West Virginia Health Care Authority s (WVHCA) hospital discharge database. Data are submitted by

More information

Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment

Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment This webinar will be recorded and available on the NPIC/QAS website www.npic.org. Nurse Planner:

More information

Glenbeigh 2017 CHNA Implementation Strategy

Glenbeigh 2017 CHNA Implementation Strategy Glenbeigh 2017 CHNA Implementation Strategy Presented for Board Review on March 29, 2017 This document details how Glenbeigh, including its six outpatient centers, will address the needs found in the Community

More information